Modeling and control for in Vitro combination therapy using ONYX-015 replicating adenovirus

Proceedings of the American Control Conference

Volumn 2006, Issue , 2006, Pages 4794-4799

  Zurakowski, Ryan ^a   Wodarz, Dominik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; OPTIMAL CONTROL SYSTEMS; TUMORS; VIRUSES;

COXSACKIE AND ADENO VIRUS RECEPTOR (CAR); MALIGNANT CELLS; VIRAL ATTACKS;

CONTROL SYSTEM ANALYSIS;

EID: 34047220305     PISSN: 07431619     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/acc.2006.1657479     Document Type: Conference Paper

References (15)

1. J. R. Bischoff, D. H. Kim, A. Williams, C. Reise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick, "An adenovirus mutant that replicates selectively in p53deficient human tumor cells." Science, vol. 274, no. 5286, pp. 373-6, Oct 1996.
2. S. J. Ries, C. H. Brandts, A. S. Chung, C. H. Biederer, B. C. Hann, E. M. Lipner, F. McCormick, and W. M. Korn, "Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl 1520 (ONYX-015)." Nat Med, vol. 6, no. 10, pp. 1128-33, Oct 2000.
3. W. M. Gallagher and R. Brown, "p53-oriented cancer therapies: current progress." Ann Oncol, vol. 10, no. 2, pp. 139-50, Feb 1999.
4. F. R. Khuri, J. Nemunaitis, I. Ganly, J. Arseneau, I. F. Tannock, L. Romel, M. Gore, J. Ironside, R. H. MacDougall, C. Heise, B. Randlev, A. M. Gillenwater, P. Bruso, S. B. Kaye, W. K. Hong, and D. H. Kim, "a controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer." Nat Med, vol. 6, no. 8, pp. 879-85, Aug 2000.
5. T. Reid, E. Galanis, J. Abbruzzese, D. Sze, J. Andrews, L. Romel, M. Hatfield, J. Rubin, and D. Kirn, "Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial." Gene Ther, vol. 8, no. 21, pp. 1618-26, Nov 2001.
6. S. Ries and W. M. Korn, "ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus." Br J Cancer, vol. 86, no. 1, pp. 5-11, Jan 2002.
7. S. Mulvihill, R. Warren, A. Venook, A. Adler, B. Randlev, C. Heise, and D. Kirn, "Safety and feasibility of injection with an E IB-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial." Gene Ther, vol. 8, no. 4, pp. 308-15, Feb 2001.
8. J. R. Hecht, R. Bedford, J. L. Abbruzzese, S. Lahoti, T. R. Reid, R. M. Soetikno, D. H. Kirn, and S. M. Freeman, "A phase I/II trial of intratumoral endoscopie ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma." Clin Cancer Res, vol. 9, no. 2, pp. 555-61, Feb 2003.
9. J. M. Bergelson, J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg, "Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5." Science, vol. 275, no. 5304, pp. 1320-3, Feb 1997.
10. T. J. Wickham, E. J. Filardo, D. A. Cheresh, and G. R. Nemerow, "Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization." J Cell Biol, vol. 127, no. 1, pp. 257-64, Oct 1994.
11. P. Mathias, T. Wickham, M. Moore, and G. Nemerow, "Multiple adenovirus serotypes use alpha v integrins for infection." J Viral, vol. 68, no. 10, pp. 6811-4, Oct 1994.
12. C. Hidaka, E. Milano, P. L. Leopold, J. M. Bergelson, N. R. Hackett, R. W. Finberg, T. J. Wickham, I. Kovesdi, P. Roelvink, and R. G. Crystal, "CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts." J Clin Invest, vol. 103, no. 4, pp. 579-87, Feb 1999.
13. K. A. Rauen, D. Sudilovsky, J. L. Le, K. L. Chew, B. Hann, V. Weinberg, L. D. Schmitt, and F. McCormick, "Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy." Cancer Res, vol. 62, no. 13, pp. 3812-8, Jul 2002.
14. A. Kanerva and A. Hemminki, "Adenoviruses for treatment of cancer." Ann Med, vol. 37, no. 1, pp. 33-43, 2005.
15. D. Wodarz, "Viruses as antitumor weapons: defining conditions for tumor remission." Cancer Res, vol. 61, no. 8, pp. 3501-7, Apr 2001.